← Pipeline
Late preclinicalPreclinical programmeNo efficacy data yet
Development candidate / preclinical
Scripps / Lairson combination
Fixed-dose binary small-molecule combination
Practical availability: Preclinical — not available as a clinical intervention
- Compound / intervention
- Fixed-dose binary small-molecule combination
- Mechanism
- Synergistic fixed-dose small-molecule combination
- Development stage
- Development candidate / preclinical
- Status
- Candidate selected from synergistic remyelination-inducing drug combinations
- Evidence level
- Preclinical only • no proven clinical benefit in MS
Next substantive checkpoint
Pre-IND development and formal clinical-trial registration
Related substantive developments
No separate substantive update is currently linked.